ClinVar Miner

Submissions for variant NM_000539.3(RHO):c.541G>A (p.Glu181Lys)

dbSNP: rs775557680
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 15
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000724301 SCV000228901 pathogenic not provided 2014-12-18 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000724301 SCV001198576 pathogenic not provided 2024-11-04 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 181 of the RHO protein (p.Glu181Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant retinitis pigmentosa (PMID: 1833777, 29068140). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 196282). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RHO protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RHO function (PMID: 8253795, 19913029). For these reasons, this variant has been classified as Pathogenic.
Blueprint Genetics RCV001074893 SCV001240497 pathogenic Retinal dystrophy 2019-08-13 criteria provided, single submitter clinical testing
Institute of Human Genetics, University of Leipzig Medical Center RCV000177081 SCV001440598 pathogenic Retinitis pigmentosa 4 2024-06-28 criteria provided, single submitter clinical testing Criteria applied: PS3,PS4,PM1,PM2,PP3
Centre for Genomic Medicine, Manchester, Central Manchester University Hospitals RCV000177081 SCV001443228 pathogenic Retinitis pigmentosa 4 2020-09-01 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000724301 SCV001962524 pathogenic not provided 2023-10-01 criteria provided, single submitter clinical testing RHO: PP1:Strong, PM1, PM2, PS4:Moderate, PS3:Supporting
Dept Of Ophthalmology, Nagoya University RCV001074893 SCV004705660 likely pathogenic Retinal dystrophy 2023-10-01 criteria provided, single submitter research
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV001074893 SCV005071447 pathogenic Retinal dystrophy 2020-01-01 criteria provided, single submitter clinical testing
NIHR Bioresource Rare Diseases, University of Cambridge RCV000504731 SCV000598752 likely pathogenic Retinitis pigmentosa 2015-01-01 no assertion criteria provided research
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000177081 SCV000804694 pathogenic Retinitis pigmentosa 4 2016-09-01 no assertion criteria provided clinical testing
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet RCV000504731 SCV000926675 pathogenic Retinitis pigmentosa 2018-04-01 no assertion criteria provided research
Sharon lab, Hadassah-Hebrew University Medical Center RCV000504731 SCV001161245 likely pathogenic Retinitis pigmentosa 2019-06-23 no assertion criteria provided research
Clinical Genetics, Academic Medical Center RCV000724301 SCV001978866 pathogenic not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000724301 SCV001979581 pathogenic not provided no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004755791 SCV005362760 pathogenic RHO-related disorder 2024-08-22 no assertion criteria provided clinical testing The RHO c.541G>A variant is predicted to result in the amino acid substitution p.Glu181Lys. This variant has been reported many times as causative for autosomal dominant retinitis pigmentosa (see for examples: Dryja et al. 1991. PubMed ID: 1833777; Sohocki et al. 2001. PubMed ID: 11139241; Eisenberger et al. 2013. PubMed ID: 24265693: Table S4, Panneman et al. 2023. PubMed ID: 36819107). This variant has not been reported in the large population database gnomAD, indicating this variant is rare. This variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/196282). Given the evidence, we interpret this variant as pathogenic for autosomal dominant disease.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.